Poster

The importance of RAS and BRAF in metastatic colorectal cancer – real-world evidence from North-East Romania

BackgroundRAS genes are prognostic and predictive genetic biomarkers for the anti-EGFR treatment in metastatic colorectal cancer (mCRC), having an important impact on treatment management...

06/25/2023

Value of liquid biopsy in taking faster medical decisions in colorectal cancer patients. Its clinical application in an Argentinian cancer institution

BackgroundTime to take medical decision is very important for cancer patients. In general patients demand and require answers to understand their oncology disease. In the last years genom...

06/25/2023

Impact of tumor location on clinicohistological profile and oncological outcomes in Tunisian population

BackgroundSidedness of colorectal cancer (CRC) can reveal different presentation, molecular alteration, histology, and outcome. Left-sided CRC are known to have a better prognosis in term...

06/25/2023

Use of prophylactic and reactive feeding tubes in patients with esophageal cancer: A single-centre cohort study

BackgroundEsophageal cancer (EC) patients suffer from significant cachexia prior to and during treatment with chemotherapy and radiation (CRT). Feeding tubes can become the primary form o...

06/25/2023

Factors affecting progression-free survival (PFS) for patients with metastatic colorectal cancer (mCRC) receiving regorafenib or for patients after re-challenge previously effective chemotherapy (CT) regimens in third or following lines

BackgroundRegorafenib is considered the standard third-line therapy of mCRC, which has demonstrated a survival benefit over placebo in randomized trials. Another, less proven approach is ...

06/25/2023

Pancreatic cancer oral inverse agonist of RORgT receptor targets primary cancer cells and alters inflammatory mediators of the tumor microenvironment

BackgroundPancreatic cancer is the fourth deadliest cancer for both men and women. Current five-year survival rate is 12% increased to 44% for the 15% with localized disease and most pati...

06/25/2023

Real--world evidence of gastrointestinal stromal tumors (GIST) patients with second primary malignant tumors (SPMT)

BackgroundGISTs are rare; constituting 1% of all sarcomas and 3–5% of gastrointestinal tumors1. Most frequently originated from the stomach and small intestine2. There are several tumours...

06/25/2023

NER repair system and predisposition to hereditary colorectal cancer: ERCC1 novel mutation in a Tunisian family

BackgroundSeveral DNA repair pathways are implicated in heriditary colorectal cancer predisposition. Mismatch Repair (MMR) is the most common repair system of damaged DNA and in maintaini...

06/25/2023

Gastric cancer risk factors knowledge in Mexican population. LEGACy 3A

BackgroundGastric cancer (GC) is the fifth leading cause of cancer incidence, and fourth in mortality worldwide. The LEGACy study is a multi-institutional study between Europe and Latin A...

06/25/2023

Survival outcomes and prognostic factors in high risk locally advanced rectal cancers (LARC) undergoing concurrent capecitabine and long course radiation (Cape – RT) – results of a large cohort study

BackgroundChemoradiation with Cape – RT is the standard of care in patients with LARC, though total neoadjuvant therapy might improve survival outcomes. Establishing baseline outcomes wit...

Puneet Bhargava ;

M. Reddy Yallala ;

A. Shah ;

V. Ostwal ;

A. Saklani ;

M. Kazi ;

R. Engineer ;

S. Srinivas ;

A. Ramaswamy ;

A. Ankathi ;

A. Baheti ;

06/25/2023